Why are small-molecule GLP-1 agonists valuable for early-stage mechanistic research
Early clinical data from Palatin indicated that bremelanotide on its own, and even more so combined with a PDE5i, produced statistically significant improvements in erectile function in men
Since the formation of OAA from its precursor, malate, is thermodynamically unfavorable, the highly exergonic nature of the citrate synthase reaction is of central importance in keeping the entire cycle going in the forward direction, since it drives oxaloacetate formation by mass action principals
It uses Carnipure, a patented and clinically studied form of L-Carnitine, and is safe for long-term use with no stimulants or habit-forming ingredients
The FDA decision is anticipated in 2H2025
Retatrutide has a half-life of approximately 6 days, supporting weekly dosing in research models